India vs USA T20 World Cup 2026: Match Details, Squad, and How to Watch Live

Haemonetics reported Q3 2026 earnings, with revenue of $339 million and adjusted earnings per share of $1.31, up 10% from the previous quarter. The company raised its full-year revenue, earnings, and free cash flow guidance, driven by strong performance from Nexus and TEG products. Hospital revenue was down 1% in the quarter, while Blood Management Technologies grew 8% and Interventional Technologies declined 12%.